Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 94.91B | 91.83B | 93.32B | 92.12B | 88.65B | 94.23B |
Gross Profit | 44.40B | 42.95B | 43.94B | 42.16B | 40.36B | 42.72B |
EBITDA | 2.69B | 2.80B | 2.33B | -1.79B | -1.95B | -4.40B |
Net Income | 2.13B | 2.92B | 1.85B | -2.60B | -3.98B | -5.00B |
Balance Sheet | ||||||
Total Assets | 81.11B | 79.08B | 84.76B | 87.21B | 90.68B | 99.61B |
Cash, Cash Equivalents and Short-Term Investments | 25.16B | 26.40B | 26.60B | 25.90B | 32.03B | 36.53B |
Total Debt | 854.00M | 799.00M | 1.05B | 1.17B | 1.59B | 3.32B |
Total Liabilities | 29.62B | 27.04B | 32.91B | 35.86B | 35.22B | 37.14B |
Stockholders Equity | 51.49B | 52.03B | 50.80B | 49.84B | 53.53B | 60.05B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.10B | 2.10B | -4.29B | -4.48B | -3.35B |
Operating Cash Flow | 0.00 | 2.82B | 2.99B | -2.98B | -3.60B | -1.72B |
Investing Cash Flow | 0.00 | -3.16B | -731.00M | -2.38B | 2.58B | -812.00M |
Financing Cash Flow | 0.00 | -1.37B | -1.29B | -1.38B | -3.47B | -1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥59.93B | 13.56 | 3.61% | 12.39% | -11.38% | ||
69 Neutral | ¥44.14B | 10.83 | 3.79% | 2.00% | -28.32% | ||
68 Neutral | ¥38.89B | 14.47 | 2.83% | -1.59% | 57.60% | ||
68 Neutral | ¥37.26B | 27.06 | 4.78% | 16.33% | 5.84% | ||
66 Neutral | £1.85B | 11.29 | 6.20% | 3.10% | 0.61% | -17.57% | |
60 Neutral | ¥28.63B | ― | 4.78% | -3.50% | -372.92% | ||
50 Neutral | ¥8.02B | ― | 2.07% | -9.83% | -371.31% |